Page last updated: 2024-12-05

mevinphos

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

Mevinphos: An organophosphate cholinesterase inhibitor that is used as an insecticide. [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID5355863
CHEMBL ID1903674
CHEBI ID38725
SCHEMBL ID25891
MeSH IDM0013716

Synonyms (128)

Synonym
phosdrin,.beta.
phosdrin, .alpha.
2-butenoic acid, 3-[(dimethoxyphosphinyl)oxy]-, methyl ester
methyl 3-[(dimethoxyphosphinyl)oxy]butenoate, .alpha. & .beta. isomers
phosphoric acid, ester with methyl 3-hydroxycrotonate
gestid
dimethyl-1-carbomethoxy-1-propen-2-yl phosphate
2-carbomethoxy-1-methylvinyl dimethyl phosphate
phosphate de dimethyle et de 2-methoxycarbonyl-1 methylvinyle
(.alpha.-2-carbomethoxy-1-methylvinyl) dimethyl phosphate
gesfid
(cis-2-methoxycarbonyl-1-methylvinyl) dimethyl phosphate
2-carbomethoxy-1-propen-2-yl dimethyl phosphate
compound 2046
fosdrin
(2-methoxycarbonyl-1-methyl-vinyl)-dimethyl-fosfaat
o,o-dimethyl o-(1-methyl-2-carboxyvinyl) phosphate
3-hydroxycrotonic acid methyl ester dimethyl phosphate
(2-methoxycarbonyl-1-methyl-vinyl)-dimethyl-phosphat
dimethyl phosphate of methyl 3-hydroxy-cis-crotonate
crotonic acid, methyl ester, dimethyl phosphate
os 2046
dimethyl methoxycarbonylpropenyl phosphate
ent 22,374
phosdrin
nsc-46470
(2-metossicarbonil-1-metil-vinil)-dimetil-fosfato
dimethyl (1-methoxycarboxypropen-2-yl)phosphate
pd 5
o,o-dimethyl-o-(2-carbomethoxy-1-methylvinyl) phosphate
nsc46470
crotonic acid, methyl ester, dimethyl phosphate, (e)-
cis-phosdrin
meniphos
mevinphos
o,o-dimethyl-o-2-carbomethoxy-1-methylvinyl phosphate
wln: 1ov1uy1&opo&o1&o1
dimethyl (2-methoxycarbonyl-1-methylvinyl) phosphate
menite
2-methoxycarbonyl-1-methylvinyl dimethyl phosphate
methyl 3-(dimethoxyphosphinyloxy)crotonate
phosphoric acid, (1-methoxycarboxypropen-2-yl) dimethyl ester
3-[(dimethoxyphosphinyl)oxy]-2-butenoic acid, methyl ester
mevinfos
7786-34-7
2-carbomethoxy-1-methylvinyl dimethyl phosphate, .alpha. isomer
phosfene
cmdp
crotonic acid, 3-hydroxy-, methyl ester, dimethyl phosphate, (e)-
crotonic acid, 3-hydroxy-, methyl ester, dimethyl phosphate
epa pesticide chemical code 015801
mevinfos [dutch]
o,o-dimethyl 1-carbomethoxy-1-propen-2-yl phosphate
phosphoric acid, dimethyl ester, ester with methyl 3-hydroxycrotonate
hsdb 777
2-butenoic acid, 3-((dimethoxyphosphinyl)oxy)-, methyl ester
einecs 232-095-1
(2-methoxycarbonyl-1-methyl-vinyl)-dimethyl-phosphat [german]
methyl-3-hydroxy-alpha-crotonate, dimethyl phosphate ester
ai3-22374
methyl 3-((dimethoxyphosphinyl)oxy)crotonat, (e)-
o,o-dimethyl-o-2-methoxycarbonyl-1-methyl-vinyl-phosphat [german]
2-butenoic acid, 3-((dimethoxyphosphinyl)oxy)-, methyl ester, (e)-
(e)-mevinphos
alpha-mevinphos
methyl 3-hydroxy-alpha-crotonate dimethyl phosphate
mevinphos [bsi:iso]
cis-mevinphos
(2-metossicarbonil-1-metil-vinil)-dimetil-fosfato [italian]
einecs 206-051-7
phosphate de dimethyle et de 2-methoxycarbonyl-1 methylvinyle [french]
nsc 46470
brn 1793349
dimethyl 2-methoxycarbonyl-1-methylvinyl phosphate
pd 5 (pesticide)
caswell no. 160b
3-((dimethoxyphosphinyl)oxy)-2-butenoic acid methyl ester
methyl 3-(dimethoxyphosphinoyloxy)but-2-enoate
(2-methoxycarbonyl-1-methyl-vinyl)-dimethyl-fosfaat [dutch]
duraphos
CHEBI:38725
methyl 3-hydroxycrotonate dimethyl phosphate ester
1-methoxycarbonyl-1-propen-2-yl dimethyl phosphate
methyl 3-[(dimethoxyphosphoryl)oxy]but-2-enoate
methyl 3-((dimethoxyphosphinyl)oxy)-2-butenoate
NCGC00163817-01
methyl (2e)-3-[(dimethoxyphosphoryl)oxy]but-2-enoate
NCGC00163817-02
methyl (e)-3-dimethoxyphosphoryloxybut-2-enoate
inchi=1/c7h13o6p/c1-6(5-7(8)10-2)13-14(9,11-3)12-4/h5h,1-4h3/b6-5+
gepdyqsqvlxleu-aatrikpksa-
NCGC00163817-03
NCGC00163817-04
C18688
unii-14zyo4ikxt
14zyo4ikxt ,
o,o-dimethyl-o-2-methoxycarbonyl-1-methyl-vinyl-phosphat
NCGC00255051-01
cas-7786-34-7
tox21_301153
dtxcid40809716
dtxsid2032683 ,
unii-q6vsz656wv
q6vsz656wv ,
2-butenoic acid, 3-((dimethoxyphosphinyl)oxy)-, methyl ester, (2e)-
298-01-1
AKOS015902589
26718-65-0
2-butenoic acid,3-[(dimethoxyphosphinyl)oxy]-, methyl ester
mevinphos, (e)-
mevinphos, cis-
SCHEMBL25891
DTXSID0058358
GEPDYQSQVLXLEU-UHFFFAOYSA-N
CHEMBL1903674
2-butenoic acid, 3-[(dimethoxyphosphinyl)oxy]-, methyl ester, (2e)-
apavinphos
.alpha.-mevinphos
GEPDYQSQVLXLEU-AATRIKPKSA-N
2-butenoic acid, 3-[(dimethoxyphosphinyl)oxy]-, methyl ester, (e)-
methyl (2e)-3-[(dimethoxyphosphoryl)oxy]-2-butenoate
(e)-mevinphos (cis-butenoic acid)
pesticide1_mevinphos isomer 1*_c7h13o6p_2-butenoic acid, 3-[(dimethoxyphosphinyl)oxy]-, methyl ester, (2e)-
mevindrin
(e)-methyl 3-(dimethoxyphosphoryloxy)but-2-enoate
Q413540
(e)-mevinphos (cis-butenoic acid) 100 microg/ml in acetonitrile
e-mevinphos

Research Excerpts

Toxicity

ExcerptReferenceRelevance
"The efficacy of cholinesterase reactivators tetroxime, HI-6 and obidoxime in combination with atropine against highly toxic organophosphate soman as well as organophosphorus insecticide fosdrin was evaluated in male mice using median lethal dose (LD50) for 48 hours."( [Comparison of the effect of selected cholinesterase reactivators combined with atropine on soman and fosdrin toxicity in mice].
Kassa, J, 1995
)
0.29
"The therapeutic efficacy of the new asymmetric bispyridinium oxime BI-6 against acute toxicity of the highly toxic organophosphate soman and the organophosphorus insecticide fosdrin by means of affecting the LD50 values of these noxiores substances was compared with the effect of the hitherto most perspective oxime HI-6 and the classic obidoxime always in combination with the identical dose of atropine."( [Comparison of the effects of BI-6, a new asymmetric bipyridine oxime, with HI-6 oxime and obidoxime in combination with atropine on soman and fosdrine toxicity in mice].
Kassa, J, 1999
)
0.3
" On the other hand, monocrotophos, dicrotophos, and phosphamidon were somewhat more toxic to the young rat, but the magnitude of the differences was < 2-fold lower."( Age-related differences in acute neurotoxicity produced by mevinphos, monocrotophos, dicrotophos, and phosphamidon.
Moser, VC,
)
0.13

Compound-Compound Interactions

ExcerptReferenceRelevance
"The efficacy of cholinesterase reactivators tetroxime, HI-6 and obidoxime in combination with atropine against highly toxic organophosphate soman as well as organophosphorus insecticide fosdrin was evaluated in male mice using median lethal dose (LD50) for 48 hours."( [Comparison of the effect of selected cholinesterase reactivators combined with atropine on soman and fosdrin toxicity in mice].
Kassa, J, 1995
)
0.29
"The therapeutic efficacy of the new asymmetric bispyridinium oxime BI-6 against acute toxicity of the highly toxic organophosphate soman and the organophosphorus insecticide fosdrin by means of affecting the LD50 values of these noxiores substances was compared with the effect of the hitherto most perspective oxime HI-6 and the classic obidoxime always in combination with the identical dose of atropine."( [Comparison of the effects of BI-6, a new asymmetric bipyridine oxime, with HI-6 oxime and obidoxime in combination with atropine on soman and fosdrine toxicity in mice].
Kassa, J, 1999
)
0.3

Dosage Studied

There was a known ingested dosage of 28 g. Repetitive dosing with mevinphos did not cause any discernible histopathological effects in mice or rats, nor was it oncogenic in either species.

ExcerptRelevanceReference
" Repetitive dosing with mevinphos did not cause any discernible histopathological effects in mice or rats, nor was it oncogenic in either species."( Risks from occupational and dietary exposure to mevinphos.
Cochran, RC; Formoli, TA; Kellner, TP; Lewis, CM; Pfeifer, KF; Silva, MH, 1996
)
0.29
" That some patients still yielded to acute organophosphate poisoning despite repeated dosing of atropine suggests that cellular mechanisms that are independent of muscarinic receptor activation may also be engaged in organophosphate poisoning."( Muscarinic receptor-independent activation of cyclic adenosine monophosphate-dependent protein kinase in rostral ventrolateral medulla underlies the sympathoexcitatory phase of cardiovascular responses during mevinphos intoxication in the rat.
Chan, SH; Chang, AY; Tsai, CY; Wu, CH, 2007
)
0.34
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (20)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
acetylcholinesteraseHomo sapiens (human)Potency6.15850.002541.796015,848.9004AID1347395; AID1347397; AID1347398; AID1347399
hypoxia-inducible factor 1 alpha subunitHomo sapiens (human)Potency54.94103.189029.884159.4836AID1224846
SMAD family member 2Homo sapiens (human)Potency0.17370.173734.304761.8120AID1346924
SMAD family member 3Homo sapiens (human)Potency0.17370.173734.304761.8120AID1346924
AR proteinHomo sapiens (human)Potency27.59420.000221.22318,912.5098AID588516; AID743035; AID743063
progesterone receptorHomo sapiens (human)Potency27.30600.000417.946075.1148AID1346795
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency29.81030.001530.607315,848.9004AID1224841; AID1224842; AID1224848; AID1224849; AID1259401; AID1259403
farnesoid X nuclear receptorHomo sapiens (human)Potency30.89560.375827.485161.6524AID743217
pregnane X nuclear receptorHomo sapiens (human)Potency31.62280.005428.02631,258.9301AID720659
estrogen nuclear receptor alphaHomo sapiens (human)Potency17.88070.000229.305416,493.5996AID588513; AID743075
peroxisome proliferator-activated receptor deltaHomo sapiens (human)Potency38.89520.001024.504861.6448AID743227
peroxisome proliferator activated receptor gammaHomo sapiens (human)Potency18.55850.001019.414170.9645AID588537; AID743191
vitamin D (1,25- dihydroxyvitamin D3) receptorHomo sapiens (human)Potency0.00200.023723.228263.5986AID588543
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_aHomo sapiens (human)Potency68.58960.001723.839378.1014AID743083
thyroid stimulating hormone receptorHomo sapiens (human)Potency15.35530.001628.015177.1139AID1259385
activating transcription factor 6Homo sapiens (human)Potency17.37390.143427.612159.8106AID1159516
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_aHomo sapiens (human)Potency69.166619.739145.978464.9432AID1159509
heat shock protein beta-1Homo sapiens (human)Potency30.89560.042027.378961.6448AID743210
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency61.13060.000627.21521,122.0200AID743202
Cellular tumor antigen p53Homo sapiens (human)Potency13.68540.002319.595674.0614AID651631
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (124)

Processvia Protein(s)Taxonomy
negative regulation of cell population proliferationCellular tumor antigen p53Homo sapiens (human)
regulation of cell cycleCellular tumor antigen p53Homo sapiens (human)
regulation of cell cycle G2/M phase transitionCellular tumor antigen p53Homo sapiens (human)
DNA damage responseCellular tumor antigen p53Homo sapiens (human)
ER overload responseCellular tumor antigen p53Homo sapiens (human)
cellular response to glucose starvationCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
regulation of apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
positive regulation of miRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
negative regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
mitophagyCellular tumor antigen p53Homo sapiens (human)
in utero embryonic developmentCellular tumor antigen p53Homo sapiens (human)
somitogenesisCellular tumor antigen p53Homo sapiens (human)
release of cytochrome c from mitochondriaCellular tumor antigen p53Homo sapiens (human)
hematopoietic progenitor cell differentiationCellular tumor antigen p53Homo sapiens (human)
T cell proliferation involved in immune responseCellular tumor antigen p53Homo sapiens (human)
B cell lineage commitmentCellular tumor antigen p53Homo sapiens (human)
T cell lineage commitmentCellular tumor antigen p53Homo sapiens (human)
response to ischemiaCellular tumor antigen p53Homo sapiens (human)
nucleotide-excision repairCellular tumor antigen p53Homo sapiens (human)
double-strand break repairCellular tumor antigen p53Homo sapiens (human)
regulation of DNA-templated transcriptionCellular tumor antigen p53Homo sapiens (human)
regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
protein import into nucleusCellular tumor antigen p53Homo sapiens (human)
autophagyCellular tumor antigen p53Homo sapiens (human)
DNA damage responseCellular tumor antigen p53Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrestCellular tumor antigen p53Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediatorCellular tumor antigen p53Homo sapiens (human)
transforming growth factor beta receptor signaling pathwayCellular tumor antigen p53Homo sapiens (human)
Ras protein signal transductionCellular tumor antigen p53Homo sapiens (human)
gastrulationCellular tumor antigen p53Homo sapiens (human)
neuroblast proliferationCellular tumor antigen p53Homo sapiens (human)
negative regulation of neuroblast proliferationCellular tumor antigen p53Homo sapiens (human)
protein localizationCellular tumor antigen p53Homo sapiens (human)
negative regulation of DNA replicationCellular tumor antigen p53Homo sapiens (human)
negative regulation of cell population proliferationCellular tumor antigen p53Homo sapiens (human)
determination of adult lifespanCellular tumor antigen p53Homo sapiens (human)
mRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
rRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
response to salt stressCellular tumor antigen p53Homo sapiens (human)
response to inorganic substanceCellular tumor antigen p53Homo sapiens (human)
response to X-rayCellular tumor antigen p53Homo sapiens (human)
response to gamma radiationCellular tumor antigen p53Homo sapiens (human)
positive regulation of gene expressionCellular tumor antigen p53Homo sapiens (human)
cardiac muscle cell apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of cardiac muscle cell apoptotic processCellular tumor antigen p53Homo sapiens (human)
glial cell proliferationCellular tumor antigen p53Homo sapiens (human)
viral processCellular tumor antigen p53Homo sapiens (human)
glucose catabolic process to lactate via pyruvateCellular tumor antigen p53Homo sapiens (human)
cerebellum developmentCellular tumor antigen p53Homo sapiens (human)
negative regulation of cell growthCellular tumor antigen p53Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
negative regulation of transforming growth factor beta receptor signaling pathwayCellular tumor antigen p53Homo sapiens (human)
mitotic G1 DNA damage checkpoint signalingCellular tumor antigen p53Homo sapiens (human)
negative regulation of telomere maintenance via telomeraseCellular tumor antigen p53Homo sapiens (human)
T cell differentiation in thymusCellular tumor antigen p53Homo sapiens (human)
tumor necrosis factor-mediated signaling pathwayCellular tumor antigen p53Homo sapiens (human)
regulation of tissue remodelingCellular tumor antigen p53Homo sapiens (human)
cellular response to UVCellular tumor antigen p53Homo sapiens (human)
multicellular organism growthCellular tumor antigen p53Homo sapiens (human)
positive regulation of mitochondrial membrane permeabilityCellular tumor antigen p53Homo sapiens (human)
cellular response to glucose starvationCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
positive regulation of apoptotic processCellular tumor antigen p53Homo sapiens (human)
negative regulation of apoptotic processCellular tumor antigen p53Homo sapiens (human)
entrainment of circadian clock by photoperiodCellular tumor antigen p53Homo sapiens (human)
mitochondrial DNA repairCellular tumor antigen p53Homo sapiens (human)
regulation of DNA damage response, signal transduction by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
positive regulation of neuron apoptotic processCellular tumor antigen p53Homo sapiens (human)
transcription initiation-coupled chromatin remodelingCellular tumor antigen p53Homo sapiens (human)
negative regulation of proteolysisCellular tumor antigen p53Homo sapiens (human)
negative regulation of DNA-templated transcriptionCellular tumor antigen p53Homo sapiens (human)
positive regulation of DNA-templated transcriptionCellular tumor antigen p53Homo sapiens (human)
positive regulation of RNA polymerase II transcription preinitiation complex assemblyCellular tumor antigen p53Homo sapiens (human)
positive regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
response to antibioticCellular tumor antigen p53Homo sapiens (human)
fibroblast proliferationCellular tumor antigen p53Homo sapiens (human)
negative regulation of fibroblast proliferationCellular tumor antigen p53Homo sapiens (human)
circadian behaviorCellular tumor antigen p53Homo sapiens (human)
bone marrow developmentCellular tumor antigen p53Homo sapiens (human)
embryonic organ developmentCellular tumor antigen p53Homo sapiens (human)
positive regulation of peptidyl-tyrosine phosphorylationCellular tumor antigen p53Homo sapiens (human)
protein stabilizationCellular tumor antigen p53Homo sapiens (human)
negative regulation of helicase activityCellular tumor antigen p53Homo sapiens (human)
protein tetramerizationCellular tumor antigen p53Homo sapiens (human)
chromosome organizationCellular tumor antigen p53Homo sapiens (human)
neuron apoptotic processCellular tumor antigen p53Homo sapiens (human)
regulation of cell cycleCellular tumor antigen p53Homo sapiens (human)
hematopoietic stem cell differentiationCellular tumor antigen p53Homo sapiens (human)
negative regulation of glial cell proliferationCellular tumor antigen p53Homo sapiens (human)
type II interferon-mediated signaling pathwayCellular tumor antigen p53Homo sapiens (human)
cardiac septum morphogenesisCellular tumor antigen p53Homo sapiens (human)
positive regulation of programmed necrotic cell deathCellular tumor antigen p53Homo sapiens (human)
protein-containing complex assemblyCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stressCellular tumor antigen p53Homo sapiens (human)
thymocyte apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of thymocyte apoptotic processCellular tumor antigen p53Homo sapiens (human)
necroptotic processCellular tumor antigen p53Homo sapiens (human)
cellular response to hypoxiaCellular tumor antigen p53Homo sapiens (human)
cellular response to xenobiotic stimulusCellular tumor antigen p53Homo sapiens (human)
cellular response to ionizing radiationCellular tumor antigen p53Homo sapiens (human)
cellular response to gamma radiationCellular tumor antigen p53Homo sapiens (human)
cellular response to UV-CCellular tumor antigen p53Homo sapiens (human)
stem cell proliferationCellular tumor antigen p53Homo sapiens (human)
signal transduction by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
reactive oxygen species metabolic processCellular tumor antigen p53Homo sapiens (human)
cellular response to actinomycin DCellular tumor antigen p53Homo sapiens (human)
positive regulation of release of cytochrome c from mitochondriaCellular tumor antigen p53Homo sapiens (human)
cellular senescenceCellular tumor antigen p53Homo sapiens (human)
replicative senescenceCellular tumor antigen p53Homo sapiens (human)
oxidative stress-induced premature senescenceCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathwayCellular tumor antigen p53Homo sapiens (human)
oligodendrocyte apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of execution phase of apoptosisCellular tumor antigen p53Homo sapiens (human)
negative regulation of mitophagyCellular tumor antigen p53Homo sapiens (human)
regulation of mitochondrial membrane permeability involved in apoptotic processCellular tumor antigen p53Homo sapiens (human)
regulation of intrinsic apoptotic signaling pathway by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
positive regulation of miRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
negative regulation of G1 to G0 transitionCellular tumor antigen p53Homo sapiens (human)
negative regulation of miRNA processingCellular tumor antigen p53Homo sapiens (human)
negative regulation of glucose catabolic process to lactate via pyruvateCellular tumor antigen p53Homo sapiens (human)
negative regulation of pentose-phosphate shuntCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to hypoxiaCellular tumor antigen p53Homo sapiens (human)
regulation of fibroblast apoptotic processCellular tumor antigen p53Homo sapiens (human)
negative regulation of reactive oxygen species metabolic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of reactive oxygen species metabolic processCellular tumor antigen p53Homo sapiens (human)
negative regulation of stem cell proliferationCellular tumor antigen p53Homo sapiens (human)
positive regulation of cellular senescenceCellular tumor antigen p53Homo sapiens (human)
positive regulation of intrinsic apoptotic signaling pathwayCellular tumor antigen p53Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (34)

Processvia Protein(s)Taxonomy
transcription cis-regulatory region bindingCellular tumor antigen p53Homo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificCellular tumor antigen p53Homo sapiens (human)
cis-regulatory region sequence-specific DNA bindingCellular tumor antigen p53Homo sapiens (human)
core promoter sequence-specific DNA bindingCellular tumor antigen p53Homo sapiens (human)
TFIID-class transcription factor complex bindingCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription repressor activity, RNA polymerase II-specificCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription activator activity, RNA polymerase II-specificCellular tumor antigen p53Homo sapiens (human)
protease bindingCellular tumor antigen p53Homo sapiens (human)
p53 bindingCellular tumor antigen p53Homo sapiens (human)
DNA bindingCellular tumor antigen p53Homo sapiens (human)
chromatin bindingCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription factor activityCellular tumor antigen p53Homo sapiens (human)
mRNA 3'-UTR bindingCellular tumor antigen p53Homo sapiens (human)
copper ion bindingCellular tumor antigen p53Homo sapiens (human)
protein bindingCellular tumor antigen p53Homo sapiens (human)
zinc ion bindingCellular tumor antigen p53Homo sapiens (human)
enzyme bindingCellular tumor antigen p53Homo sapiens (human)
receptor tyrosine kinase bindingCellular tumor antigen p53Homo sapiens (human)
ubiquitin protein ligase bindingCellular tumor antigen p53Homo sapiens (human)
histone deacetylase regulator activityCellular tumor antigen p53Homo sapiens (human)
ATP-dependent DNA/DNA annealing activityCellular tumor antigen p53Homo sapiens (human)
identical protein bindingCellular tumor antigen p53Homo sapiens (human)
histone deacetylase bindingCellular tumor antigen p53Homo sapiens (human)
protein heterodimerization activityCellular tumor antigen p53Homo sapiens (human)
protein-folding chaperone bindingCellular tumor antigen p53Homo sapiens (human)
protein phosphatase 2A bindingCellular tumor antigen p53Homo sapiens (human)
RNA polymerase II-specific DNA-binding transcription factor bindingCellular tumor antigen p53Homo sapiens (human)
14-3-3 protein bindingCellular tumor antigen p53Homo sapiens (human)
MDM2/MDM4 family protein bindingCellular tumor antigen p53Homo sapiens (human)
disordered domain specific bindingCellular tumor antigen p53Homo sapiens (human)
general transcription initiation factor bindingCellular tumor antigen p53Homo sapiens (human)
molecular function activator activityCellular tumor antigen p53Homo sapiens (human)
promoter-specific chromatin bindingCellular tumor antigen p53Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (19)

Processvia Protein(s)Taxonomy
nuclear bodyCellular tumor antigen p53Homo sapiens (human)
nucleusCellular tumor antigen p53Homo sapiens (human)
nucleoplasmCellular tumor antigen p53Homo sapiens (human)
replication forkCellular tumor antigen p53Homo sapiens (human)
nucleolusCellular tumor antigen p53Homo sapiens (human)
cytoplasmCellular tumor antigen p53Homo sapiens (human)
mitochondrionCellular tumor antigen p53Homo sapiens (human)
mitochondrial matrixCellular tumor antigen p53Homo sapiens (human)
endoplasmic reticulumCellular tumor antigen p53Homo sapiens (human)
centrosomeCellular tumor antigen p53Homo sapiens (human)
cytosolCellular tumor antigen p53Homo sapiens (human)
nuclear matrixCellular tumor antigen p53Homo sapiens (human)
PML bodyCellular tumor antigen p53Homo sapiens (human)
transcription repressor complexCellular tumor antigen p53Homo sapiens (human)
site of double-strand breakCellular tumor antigen p53Homo sapiens (human)
germ cell nucleusCellular tumor antigen p53Homo sapiens (human)
chromatinCellular tumor antigen p53Homo sapiens (human)
transcription regulator complexCellular tumor antigen p53Homo sapiens (human)
protein-containing complexCellular tumor antigen p53Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Research

Studies (98)

TimeframeStudies, This Drug (%)All Drugs %
pre-199047 (47.96)18.7374
1990's16 (16.33)18.2507
2000's17 (17.35)29.6817
2010's13 (13.27)24.3611
2020's5 (5.10)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews4 (3.85%)6.00%
Case Studies9 (8.65%)4.05%
Observational0 (0.00%)0.25%
Other91 (87.50%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]